Table 3. Numbers of women diagnosed with HSIL+/AIS in 2013–2015, the cumulative proportion of HSIL+AIS in cytology that were followed with a biopsy anywhere in the country, within 3 month and within 1 year and women with HSIL+/AIS not followed up at the end of the following year.

		% of women followed up with histology				% of women followed up with histology				% of women followed up with histology
County	Number of women with HSIL+/AIS in cytology, 2013	Within 3 months	Within 1 year	Number of women not followed up by 31-12-2014	Number of women with HSIL+/AIS in cytology, 2014	Within 3 months	Within 1 year	Number of women not followed up by 31-12-2015	Number of women with HSIL+/AIS in cytology, 2015	Within 3 months	Within 1 year	Number of women not followed up by 31-12-2016
Stockholm	1,679	84	96	48	1,729	76	90	123	1,904	86	97	32
Uppsala	107	83	94	4	144	83	97	2	230	80	97	4
Södermanland	223	55	96	4	130	60	92	5	161	78	96	7
Östergötland	316	85	98	3	415	84	99	2	422	84	99	2
Jönköping	353	86	98	4	360	72	98	5	209	59	96	7
Kronoberg	40	45	100	0	135	41	91	3	137	53	91	3
Kalmar	219	76	97	5	168	77	98	2	270	81	100	0
Gotland	74	96	99	0	66	85	95	3	54	79	90	4
Blekinge	146	57	97	3	224	67	99	3	252	64	97	4
Skåne	1,377	76	97	37	1312	76	96	40	1,382	55	93	72
Halland	238	74	97	4	243	77	98	4	219	70	95	5
Västra Götaland	1,533	66	96	40	1,562	64	95	52	1,707	57	96	37
Värmland	166	86	97	3	304	73	98	5	400	66	97	6
Örebro	241	73	97	3	377	66	97	7	297	54	96	7
Västmanland	123	80	98	3	148	88	100	0	185	81	96	7
Dalarna	130	72	98	2	190	90	98	4	178	74	96	5
Gävleborg	152	74	97	1	123	79	97	2	123	72	97	4
Västernorrland	189	54	98	3	244	46	97	2	209	50	97	5
Jämtland	119	41	98	1	139	35	98	2	124	24	99	1
Västerbotten	422	51	96	11	397	43	96	9	469	42	96	10
Norrbotten	135	66	97	2	163	66	97	4	238	70	97	6
Sweden	7,982	71	97	181	8,573	70	96	279	9,170	66	96	228